Cancer diagnosis has evolved from a predominantly reactive approach to a proactive, precision-driven field that leverages cutting-edge technologies to detect malignancies at their earliest, most treatable stages. The Cancer Diagnostics Market represents one of the most dynamic and rapidly advancing segments within the global healthcare industry, fundamentally transforming how clinicians approach cancer screening, diagnosis, and Read.